AGA临床实践更新:常规内镜检查中发现的黏膜下病变的管理专家综述
美国胃肠病学会(AGA)发布专家综述,提出10条最佳实践建议,涵盖黏膜下病变(SEL)的活检、超声内镜(EUS)评估、取样技术、内镜切除指征及随访策略,强调根据病变大小、病理、恶性潜能和症状进行个体化管理。
要点
- EUS是评估性质不明SEL的首选方法;黏膜下病变可用隧道活检、FNA/FNB或先进内镜技术取样。
- 固有肌层来源SEL应取样(优选FNB或FNA)以区分GIST与平滑肌瘤,并评估恶性潜能。
- 脂肪瘤或异位胰腺且黏膜活检正常者无需进一步评估或监测;胃GIST>2 cm考虑切除。
核心结论
- AGA专家综述提出10条最佳实践建议,指导常规内镜发现的黏膜下病变(SEL)的评估与管理。
研究设计与样本
- 美国胃肠病学会(AGA)发布的专家综述,以最佳实践建议形式呈现,共10条。
主要发现
- 钳夹咬检、深挖活检或隧道活检有时可取得SEL的病理诊断。
- EUS是评估胃肠道性质不明SEL和/或钳夹活检组织无法诊断时的首选方法。
- 黏膜下来源SEL可用隧道活检(或深挖活检)、EUS引导下细针穿刺(FNA)、EUS引导下细针活检(FNB)或先进内镜技术(去顶或内镜黏膜切除)取样。
- 固有肌层来源SEL应取样(优选FNB或FNA)以确定病变为GIST还是平滑肌瘤;结构评估和染色有助于区分间叶肿瘤并评估其恶性潜能。
关键数值与推荐
- 最佳实践建议1:钳夹咬检、深挖活检或隧道活检有时可确定SEL的病理诊断。
- 最佳实践建议2:EUS是评估胃肠道性质不明SEL和/或钳夹活检组织无法诊断时的首选方法。
- 最佳实践建议3:黏膜下来源SEL可用隧道活检(或深挖活检)、EUS引导下FNA、EUS引导下FNB或先进内镜技术(去顶或内镜黏膜切除)取样。
- 最佳实践建议4:固有肌层来源SEL应取样(优选FNB或FNA)以确定病变为GIST还是平滑肌瘤;结构评估和染色有助于区分间叶肿瘤并评估恶性潜能。
- 最佳实践建议5:内镜切除技术已用于切除SEL,应限于熟练掌握先进组织切除技术的内镜医师。
临床怎么用
- 最佳实践建议6:每个SEL的管理取决于病变大小、组织病理学、恶性潜能和症状。
- 最佳实践建议7:内镜表现符合脂肪瘤或异位胰腺且黏膜活检正常的SEL无需进一步评估或监测。
- 最佳实践建议8:固有肌层来源且小于2 cm的SEL应考虑使用EUS监测。
- 最佳实践建议9:胃GIST大于2 cm应考虑切除。
- 最佳实践建议10:溃疡、出血或引起症状的SEL应考虑切除。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BEST PRACTICE ADVICE 1: Forceps bite-on-bite or deep-well biopsies or tunnel biopsies can sometimes establish a pathologic diagnosis of SEL. BEST PRACTICE ADVICE 2: EUS is the modality of choice to evaluate indeterminate SEL of the GI track and/or if non-diagnostic tissue by forceps biopsies. BEST PRACTICE ADVICE 3: SEL arising from the submucosa can be sampled using tunnel biopsies (or deep-well biopsies), EUS guided fine-needle aspiration (FNA), EUS guided fine-needle biopsy (FNB), or advanced endoscopic techniques (unroofing or endoscopic submucosal resection). BEST PRACTICE ADVICE 4: SEL arising from muscularis propria should be sampled (preferably using FNB or FNA) to determine whether the lesion is a GIST or leiomyoma. Structural assessment and staining will allow differentiation of mesenchymal tumors and assessing their malignant potential. BEST PRACTICE ADVICE 5: Endoscopic resection techniques have been described for removal of SEL and should be limited to endoscopists skilled in advanced tissue resection techniques. BEST PRACTICE ADVICE 6: Management of each SEL depends on the size of the lesion, histopathology, their malignant potential, and presence of symptoms. BEST PRACTICE ADVICE 7: SEL that have an endoscopic appearance consistent with a lipoma or pancreatic rest and normal mucosal biopsies do not need further evaluation or surveillance. BEST PRACTICE ADVICE 8: For SEL arising from muscularis propria that are less than 2 cm in size, surveillance using EUS should be considered. BEST PRACTICE ADVICE 9: Gastric GIST larger than 2 cm should be considered for resection. BEST PRACTICE ADVICE 10: Subepithelial lesions that are ulcerated, bleeding, or causing symptoms should be considered for resection.
引用
- Sharzehi K, Sethi A, Savides T, et al. AGA Clinical Practice Update on Management of Subepithelial Lesions Encountered During Routine Endoscopy: Expert Review. Clin Gastroenterol Hepatol. 2022. PMID: 35842117. doi:10.1016/j.cgh.2022.05.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。